Pages that link to "Item:Q1624565"

The following pages link to On immunotherapies and cancer vaccination protocols: a mathematical modelling approach (Q1624565):

Displaying 31 items.

• A cancer treatment based on synergy between anti-angiogenic and immune cell therapies (Q305603) (← links)
• Mathematical model of tumor-immune surveillance (Q307632) (← links)
• Qualitative and computational analysis of a mathematical model for tumor-immune interactions (Q410989) (← links)
• Identifying and characterising the impact of excitability in a mathematical model of tumour-immune interactions (Q827852) (← links)
• Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: implications for therapeutic targeting strategies (Q1649405) (← links)
• Modelling the immune response to cancer: an individual-based approach accounting for the difference in movement between inactive and activated T cells (Q1670474) (← links)
• A mathematical model of treatment of cancer stem cells with immunotherapy (Q1684540) (← links)
• Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma (Q1720105) (← links)
• Optimal control of tumour-immune model with time-delay and immuno-chemotherapy (Q2010733) (← links)
• Optimal control for cancer treatment mathematical model using Atangana-Baleanu-Caputo fractional derivative (Q2116142) (← links)
• Comparative study for optimal control nonlinear variable-order fractional tumor model (Q2120668) (← links)
• Dynamic analysis of a model on tumor-immune system with regulation of PD-1/PD-L1 and stimulation delay of tumor antigen (Q2156325) (← links)
• Optimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapy (Q2157844) (← links)
• A direct RBF-PU method for simulating the infiltration of cytotoxic T-lymphocytes into the tumor microenvironment (Q2160926) (← links)
• Optimal control of inhibiting tumor, new approach to sufficient \(\varepsilon\)-optimality and numerical computation (Q2194798) (← links)
• Global stability and tumor clearance conditions for a cancer chemotherapy system (Q2200276) (← links)
• A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies (Q2206325) (← links)
• Optimal control problem for a general reaction-diffusion tumor-immune system with chemotherapy (Q2224757) (← links)
• Modeling the effect of immunotherapies on human castration-resistant prostate cancer (Q2225975) (← links)
• A minimal model of T cell avidity may identify subtherapeutic vaccine schedules (Q2240254) (← links)
• Optimal control of variable-order fractional model for delay cancer treatments (Q2245845) (← links)
• Delay differential model for tumour-immune response with chemoimmunotherapy and optimal control (Q2262736) (← links)
• Modelling of tumor cells regression in response to chemotherapeutic treatment (Q2293851) (← links)
• Optimal control and pattern formation for a haptotaxis model of solid tumor invasion (Q2334162) (← links)
• Modeling the dichotomy of the immune response to cancer: cytotoxic effects and tumor-promoting inflammation (Q2408437) (← links)
• A mathematical model for a T cell fate decision algorithm during immune response (Q2632766) (← links)
• Analysis of tumor cells in the absence and presence of chemotherapeutic treatment: the case of Caputo-Fabrizio time fractional derivative (Q2666213) (← links)
• A Mathematical Model of Gene Therapy for the Treatment of Cancer (Q2820390) (← links)
• MATHEMATICAL MODELING OF PANCREATIC CANCER TREATMENT WITH CANCER STEM CELLS (Q3390818) (← links)
• A numerical study of the nonlinear fractional mathematical model of tumor cells in presence of chemotherapeutic treatment (Q5110337) (← links)
• On Some Dynamical Properties of a Seven-Dimensional Cancer Model with Immunotherapy (Q5416511) (← links)